Karriereverlauf von Fabrice Piu
Ehemalige bekannte Positionen von Fabrice Piu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OTONOMY | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2008 | 01.01.2023 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - | - |
Ausbildung von Fabrice Piu
| École Normale Supérieure | Doctorate Degree |
| University of Lyon | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Frankreich | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Fabrice Piu
- Erfahrung
